The worldwide cataplexy pharmaceutical sector presents compelling growth trajectories as breakthrough research methodologies and advanced therapeutic modalities reshape treatment paradigms. Industry stakeholders are witnessing unprecedented market expansion driven by enhanced diagnostic precision, innovative drug development pipelines, and evolving healthcare reimbursement...